Supernus Pharmaceuticals (SUPN) EBIT (QoQ) (2011 - 2025)
Supernus Pharmaceuticals (SUPN) EBIT (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 93.46% |
| Sep 30, 2025 | -596.10% |
| Jun 30, 2025 | 218.38% |
| Mar 31, 2025 | -147.91% |
| Dec 31, 2024 | -47.59% |
| Sep 30, 2024 | 80.98% |
| Jun 30, 2024 | 815.79% |
| Mar 31, 2024 | -216.57% |
| Dec 31, 2023 | -112.24% |
| Sep 30, 2023 | 146.27% |
| Jun 30, 2023 | -439.78% |
| Mar 31, 2023 | -84.92% |
| Dec 31, 2022 | 2,354.37% |
| Sep 30, 2022 | -113.42% |
| Jun 30, 2022 | 476.82% |
| Mar 31, 2022 | -67.74% |
| Dec 31, 2021 | -81.30% |
| Sep 30, 2021 | -4.42% |
| Jun 30, 2021 | 158.16% |
| Mar 31, 2021 | -69.27% |